A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy

Condition:   Duchenne Muscular Dystrophy Interventions:   Drug: ATL1102 25mg;   Drug: ATL1102 50mg;   Drug: Placebo Sponsor:   Antisense Therapeutics Limited Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials